"BiocVersion","Genome","SourceType","SourceUrl","SourceVersion","Coordinate_1_based","DataProvider","Maintainer","DispatchClass","Title","Description","Species","TaxonomyId","RDataClass","RDataPath"
"3.10",NA,"FCS","http://imlspenticton.uzh.ch/robinson_lab/HDCytoData/",NA,TRUE,"","Lukas M. Weber <lukmweber@gmail.com>","Rda","Levine_32dim_SE","Mass cytometry (CyTOF) dataset from Levine et al. (2015), containing 32 dimensions (surface protein markers). Manually gated cell population labels are available for 14 populations. Cells are human bone marrow cells from 2 healthy donors. This dataset can be used to benchmark clustering algorithms.","Homo sapiens","9606","SummarizedExperiment","HDCytoData/Levine_32dim/Levine_32dim_SE.rda"
"3.10",NA,"FCS","http://imlspenticton.uzh.ch/robinson_lab/HDCytoData/",NA,TRUE,"","Lukas M. Weber <lukmweber@gmail.com>","Rda","Levine_32dim_flowSet","Mass cytometry (CyTOF) dataset from Levine et al. (2015), containing 32 dimensions (surface protein markers). Manually gated cell population labels are available for 14 populations. Cells are human bone marrow cells from 2 healthy donors. This dataset can be used to benchmark clustering algorithms.","Homo sapiens","9606","flowSet","HDCytoData/Levine_32dim/Levine_32dim_flowSet.rda"
"3.10",NA,"FCS","http://imlspenticton.uzh.ch/robinson_lab/HDCytoData/",NA,TRUE,"","Lukas M. Weber <lukmweber@gmail.com>","Rda","Levine_13dim_SE","Mass cytometry (CyTOF) dataset from Levine et al. (2015), containing 13 dimensions (surface protein markers). Manually gated cell population labels are available for 24 populations. Cells are human bone marrow cells from a single healthy donor. This dataset can be used to benchmark clustering algorithms.","Homo sapiens","9606","SummarizedExperiment","HDCytoData/Levine_13dim/Levine_13dim_SE.rda"
"3.10",NA,"FCS","http://imlspenticton.uzh.ch/robinson_lab/HDCytoData/",NA,TRUE,"","Lukas M. Weber <lukmweber@gmail.com>","Rda","Levine_13dim_flowSet","Mass cytometry (CyTOF) dataset from Levine et al. (2015), containing 13 dimensions (surface protein markers). Manually gated cell population labels are available for 24 populations. Cells are human bone marrow cells from a single healthy donor. This dataset can be used to benchmark clustering algorithms.","Homo sapiens","9606","flowSet","HDCytoData/Levine_13dim/Levine_13dim_flowSet.rda"
"3.10",NA,"FCS","http://imlspenticton.uzh.ch/robinson_lab/HDCytoData/",NA,TRUE,"","Lukas M. Weber <lukmweber@gmail.com>","Rda","Samusik_01_SE","Mass cytometry (CyTOF) dataset from Samusik et al. (2016), containing 39 dimensions (surface protein markers). Manually gated cell population labels are available for 24 populations. The full dataset (Samusik_all) contains cells from 10 replicate bone marrow samples from C57BL/6J mice (i.e. samples from 10 different mice); this dataset (Samusik_01) contains the data from sample 01 only. This dataset can be used to benchmark clustering algorithms.","Mus musculus","10090","SummarizedExperiment","HDCytoData/Samusik_01/Samusik_01_SE.rda"
"3.10",NA,"FCS","http://imlspenticton.uzh.ch/robinson_lab/HDCytoData/",NA,TRUE,"","Lukas M. Weber <lukmweber@gmail.com>","Rda","Samusik_01_flowSet","Mass cytometry (CyTOF) dataset from Samusik et al. (2016), containing 39 dimensions (surface protein markers). Manually gated cell population labels are available for 24 populations. The full dataset (Samusik_all) contains cells from 10 replicate bone marrow samples from C57BL/6J mice (i.e. samples from 10 different mice); this dataset (Samusik_01) contains the data from sample 01 only. This dataset can be used to benchmark clustering algorithms.","Mus musculus","10090","flowSet","HDCytoData/Samusik_01/Samusik_01_flowSet.rda"
"3.10",NA,"FCS","http://imlspenticton.uzh.ch/robinson_lab/HDCytoData/",NA,TRUE,"","Lukas M. Weber <lukmweber@gmail.com>","Rda","Samusik_all_SE","Mass cytometry (CyTOF) dataset from Samusik et al. (2016), containing 39 dimensions (surface protein markers). Manually gated cell population labels are available for 24 populations. This dataset contains cells from 10 replicate bone marrow samples from C57BL/6J mice (i.e. samples from 10 different mice). This dataset can be used to benchmark clustering algorithms.","Mus musculus","10090","SummarizedExperiment","HDCytoData/Samusik_all/Samusik_all_SE.rda"
"3.10",NA,"FCS","http://imlspenticton.uzh.ch/robinson_lab/HDCytoData/",NA,TRUE,"","Lukas M. Weber <lukmweber@gmail.com>","Rda","Samusik_all_flowSet","Mass cytometry (CyTOF) dataset from Samusik et al. (2016), containing 39 dimensions (surface protein markers). Manually gated cell population labels are available for 24 populations. This dataset contains cells from 10 replicate bone marrow samples from C57BL/6J mice (i.e. samples from 10 different mice). This dataset can be used to benchmark clustering algorithms.","Mus musculus","10090","flowSet","HDCytoData/Samusik_all/Samusik_all_flowSet.rda"
"3.10",NA,"FCS","http://imlspenticton.uzh.ch/robinson_lab/HDCytoData/",NA,TRUE,"","Lukas M. Weber <lukmweber@gmail.com>","Rda","Nilsson_rare_SE","Flow cytometry dataset from Nilsson et al. (2013), containing 13 dimensions (surface protein markers). Manually gated cell population labels are available for one rare population of hematopoietic stem cells (HSCs). Cells are human bone marrow cells from a single healthy donor. This dataset can be used to benchmark clustering algorithms for rare cell populations.","Homo sapiens","9606","SummarizedExperiment","HDCytoData/Nilsson_rare/Nilsson_rare_SE.rda"
"3.10",NA,"FCS","http://imlspenticton.uzh.ch/robinson_lab/HDCytoData/",NA,TRUE,"","Lukas M. Weber <lukmweber@gmail.com>","Rda","Nilsson_rare_flowSet","Flow cytometry dataset from Nilsson et al. (2013), containing 13 dimensions (surface protein markers). Manually gated cell population labels are available for one rare population of hematopoietic stem cells (HSCs). Cells are human bone marrow cells from a single healthy donor. This dataset can be used to benchmark clustering algorithms for rare cell populations.","Homo sapiens","9606","flowSet","HDCytoData/Nilsson_rare/Nilsson_rare_flowSet.rda"
"3.10",NA,"FCS","http://imlspenticton.uzh.ch/robinson_lab/HDCytoData/",NA,TRUE,"","Lukas M. Weber <lukmweber@gmail.com>","Rda","Mosmann_rare_SE","Flow cytometry dataset from Mosmann et al. (2014), containing 14 dimensions (7 surface protein markers and 7 signaling markers). Manually gated cell population labels are available for one rare population of activated (cytokine-producing) memory CD4 T cells. Cells are human peripheral blood cells exposed to influenza antigens, from a single healthy donor. This dataset can be used to benchmark clustering algorithms for rare cell populations.","Homo sapiens","9606","SummarizedExperiment","HDCytoData/Mosmann_rare/Mosmann_rare_SE.rda"
"3.10",NA,"FCS","http://imlspenticton.uzh.ch/robinson_lab/HDCytoData/",NA,TRUE,"","Lukas M. Weber <lukmweber@gmail.com>","Rda","Mosmann_rare_flowSet","Flow cytometry dataset from Mosmann et al. (2014), containing 14 dimensions (7 surface protein markers and 7 signaling markers). Manually gated cell population labels are available for one rare population of activated (cytokine-producing) memory CD4 T cells. Cells are human peripheral blood cells exposed to influenza antigens, from a single healthy donor. This dataset can be used to benchmark clustering algorithms for rare cell populations.","Homo sapiens","9606","flowSet","HDCytoData/Mosmann_rare/Mosmann_rare_flowSet.rda"
"3.10",NA,"FCS","http://imlspenticton.uzh.ch/robinson_lab/HDCytoData/",NA,TRUE,"","Lukas M. Weber <lukmweber@gmail.com>","Rda","Krieg_Anti_PD_1_SE","Mass cytometry (CyTOF) dataset from Krieg et al. (2018), consisting of 20 baseline samples (prior to treatment) of peripheral blood from melanoma skin cancer patients subsequently treated with anti-PD-1 immunotherapy. The samples are split across 2 conditions (non-responders and responders) and 2 batches. This dataset can be used to benchmark differential analysis algorithms used to test for differentially abundant rare cell populations.","Homo sapiens","9606","SummarizedExperiment","HDCytoData/Krieg_Anti_PD_1/Krieg_Anti_PD_1_SE.rda"
"3.10",NA,"FCS","http://imlspenticton.uzh.ch/robinson_lab/HDCytoData/",NA,TRUE,"","Lukas M. Weber <lukmweber@gmail.com>","Rda","Krieg_Anti_PD_1_flowSet","Mass cytometry (CyTOF) dataset from Krieg et al. (2018), consisting of 20 baseline samples (prior to treatment) of peripheral blood from melanoma skin cancer patients subsequently treated with anti-PD-1 immunotherapy. The samples are split across 2 conditions (non-responders and responders) and 2 batches. This dataset can be used to benchmark differential analysis algorithms used to test for differentially abundant rare cell populations.","Homo sapiens","9606","flowSet","HDCytoData/Krieg_Anti_PD_1/Krieg_Anti_PD_1_flowSet.rda"
"3.10",NA,"FCS","http://imlspenticton.uzh.ch/robinson_lab/HDCytoData/",NA,TRUE,"","Lukas M. Weber <lukmweber@gmail.com>","Rda","Bodenmiller_BCR_XL_SE","Mass cytometry (CyTOF) dataset from Bodenmiller et al. (2012), consisting of 8 paired samples (16 samples) of stimulated (BCR-XL) and unstimulated peripheral blood cells from healthy individuals. This dataset can be used to benchmark differential analysis algorithms used to test for differential states within cell populations.","Homo sapiens","9606","SummarizedExperiment","HDCytoData/Bodenmiller_BCR_XL/Bodenmiller_BCR_XL_SE.rda"
"3.10",NA,"FCS","http://imlspenticton.uzh.ch/robinson_lab/HDCytoData/",NA,TRUE,"","Lukas M. Weber <lukmweber@gmail.com>","Rda","Bodenmiller_BCR_XL_flowSet","Mass cytometry (CyTOF) dataset from Bodenmiller et al. (2012), consisting of 8 paired samples (16 samples) of stimulated (BCR-XL) and unstimulated peripheral blood cells from healthy individuals. This dataset can be used to benchmark differential analysis algorithms used to test for differential states within cell populations.","Homo sapiens","9606","flowSet","HDCytoData/Bodenmiller_BCR_XL/Bodenmiller_BCR_XL_flowSet.rda"
"3.10",NA,"FCS","http://imlspenticton.uzh.ch/robinson_lab/HDCytoData/",NA,TRUE,"","Lukas M. Weber <lukmweber@gmail.com>","Rda","Weber_AML_sim_main_5pc_SE","Semi-simulated mass cytometry (CyTOF) dataset from Weber et al. (2019), constructed by computationally 'spiking in' small percentages of AML (acute myeloid leukemia) blast cells into samples of healthy BMMCs (bone marrow mononuclear cells), simulating the phenotype of minimal residual disease (MRD) in AML patients. Main simulations. This dataset can be used to benchmark differential analysis algorithms used to test for differentially abundant rare cell populations. Raw data sourced from Levine et al. (2015), and data generation strategy modified from Arvaniti et al. (2017). See Weber et al. (2019) (paper introducing 'diffcyt' framework), Supplementary Note 1, for more details.","Homo sapiens","9606","SummarizedExperiment","HDCytoData/Weber_AML_sim/Weber_AML_sim_main_5pc_SE.rda"
"3.10",NA,"FCS","http://imlspenticton.uzh.ch/robinson_lab/HDCytoData/",NA,TRUE,"","Lukas M. Weber <lukmweber@gmail.com>","Rda","Weber_AML_sim_main_5pc_flowSet","Semi-simulated mass cytometry (CyTOF) dataset from Weber et al. (2019), constructed by computationally 'spiking in' small percentages of AML (acute myeloid leukemia) blast cells into samples of healthy BMMCs (bone marrow mononuclear cells), simulating the phenotype of minimal residual disease (MRD) in AML patients. Main simulations. This dataset can be used to benchmark differential analysis algorithms used to test for differentially abundant rare cell populations. Raw data sourced from Levine et al. (2015), and data generation strategy modified from Arvaniti et al. (2017). See Weber et al. (2019) (paper introducing 'diffcyt' framework), Supplementary Note 1, for more details.","Homo sapiens","9606","flowSet","HDCytoData/Weber_AML_sim/Weber_AML_sim_main_5pc_flowSet.rda"
"3.10",NA,"FCS","http://imlspenticton.uzh.ch/robinson_lab/HDCytoData/",NA,TRUE,"","Lukas M. Weber <lukmweber@gmail.com>","Rda","Weber_AML_sim_main_1pc_SE","Semi-simulated mass cytometry (CyTOF) dataset from Weber et al. (2019), constructed by computationally 'spiking in' small percentages of AML (acute myeloid leukemia) blast cells into samples of healthy BMMCs (bone marrow mononuclear cells), simulating the phenotype of minimal residual disease (MRD) in AML patients. Main simulations. This dataset can be used to benchmark differential analysis algorithms used to test for differentially abundant rare cell populations. Raw data sourced from Levine et al. (2015), and data generation strategy modified from Arvaniti et al. (2017). See Weber et al. (2019) (paper introducing 'diffcyt' framework), Supplementary Note 1, for more details.","Homo sapiens","9606","SummarizedExperiment","HDCytoData/Weber_AML_sim/Weber_AML_sim_main_1pc_SE.rda"
"3.10",NA,"FCS","http://imlspenticton.uzh.ch/robinson_lab/HDCytoData/",NA,TRUE,"","Lukas M. Weber <lukmweber@gmail.com>","Rda","Weber_AML_sim_main_1pc_flowSet","Semi-simulated mass cytometry (CyTOF) dataset from Weber et al. (2019), constructed by computationally 'spiking in' small percentages of AML (acute myeloid leukemia) blast cells into samples of healthy BMMCs (bone marrow mononuclear cells), simulating the phenotype of minimal residual disease (MRD) in AML patients. Main simulations. This dataset can be used to benchmark differential analysis algorithms used to test for differentially abundant rare cell populations. Raw data sourced from Levine et al. (2015), and data generation strategy modified from Arvaniti et al. (2017). See Weber et al. (2019) (paper introducing 'diffcyt' framework), Supplementary Note 1, for more details.","Homo sapiens","9606","flowSet","HDCytoData/Weber_AML_sim/Weber_AML_sim_main_1pc_flowSet.rda"
"3.10",NA,"FCS","http://imlspenticton.uzh.ch/robinson_lab/HDCytoData/",NA,TRUE,"","Lukas M. Weber <lukmweber@gmail.com>","Rda","Weber_AML_sim_main_0.1pc_SE","Semi-simulated mass cytometry (CyTOF) dataset from Weber et al. (2019), constructed by computationally 'spiking in' small percentages of AML (acute myeloid leukemia) blast cells into samples of healthy BMMCs (bone marrow mononuclear cells), simulating the phenotype of minimal residual disease (MRD) in AML patients. Main simulations. This dataset can be used to benchmark differential analysis algorithms used to test for differentially abundant rare cell populations. Raw data sourced from Levine et al. (2015), and data generation strategy modified from Arvaniti et al. (2017). See Weber et al. (2019) (paper introducing 'diffcyt' framework), Supplementary Note 1, for more details.","Homo sapiens","9606","SummarizedExperiment","HDCytoData/Weber_AML_sim/Weber_AML_sim_main_0.1pc_SE.rda"
"3.10",NA,"FCS","http://imlspenticton.uzh.ch/robinson_lab/HDCytoData/",NA,TRUE,"","Lukas M. Weber <lukmweber@gmail.com>","Rda","Weber_AML_sim_main_0.1pc_flowSet","Semi-simulated mass cytometry (CyTOF) dataset from Weber et al. (2019), constructed by computationally 'spiking in' small percentages of AML (acute myeloid leukemia) blast cells into samples of healthy BMMCs (bone marrow mononuclear cells), simulating the phenotype of minimal residual disease (MRD) in AML patients. Main simulations. This dataset can be used to benchmark differential analysis algorithms used to test for differentially abundant rare cell populations. Raw data sourced from Levine et al. (2015), and data generation strategy modified from Arvaniti et al. (2017). See Weber et al. (2019) (paper introducing 'diffcyt' framework), Supplementary Note 1, for more details.","Homo sapiens","9606","flowSet","HDCytoData/Weber_AML_sim/Weber_AML_sim_main_0.1pc_flowSet.rda"
"3.10",NA,"FCS","http://imlspenticton.uzh.ch/robinson_lab/HDCytoData/",NA,TRUE,"","Lukas M. Weber <lukmweber@gmail.com>","Rda","Weber_AML_sim_main_blasts_all_SE","Semi-simulated mass cytometry (CyTOF) dataset from Weber et al. (2019), constructed by computationally 'spiking in' small percentages of AML (acute myeloid leukemia) blast cells into samples of healthy BMMCs (bone marrow mononuclear cells), simulating the phenotype of minimal residual disease (MRD) in AML patients. Main simulations. This dataset can be used to benchmark differential analysis algorithms used to test for differentially abundant rare cell populations. Raw data sourced from Levine et al. (2015), and data generation strategy modified from Arvaniti et al. (2017). See Weber et al. (2019) (paper introducing 'diffcyt' framework), Supplementary Note 1, for more details.","Homo sapiens","9606","SummarizedExperiment","HDCytoData/Weber_AML_sim/Weber_AML_sim_main_blasts_all_SE.rda"
"3.10",NA,"FCS","http://imlspenticton.uzh.ch/robinson_lab/HDCytoData/",NA,TRUE,"","Lukas M. Weber <lukmweber@gmail.com>","Rda","Weber_AML_sim_main_blasts_all_flowSet","Semi-simulated mass cytometry (CyTOF) dataset from Weber et al. (2019), constructed by computationally 'spiking in' small percentages of AML (acute myeloid leukemia) blast cells into samples of healthy BMMCs (bone marrow mononuclear cells), simulating the phenotype of minimal residual disease (MRD) in AML patients. Main simulations. This dataset can be used to benchmark differential analysis algorithms used to test for differentially abundant rare cell populations. Raw data sourced from Levine et al. (2015), and data generation strategy modified from Arvaniti et al. (2017). See Weber et al. (2019) (paper introducing 'diffcyt' framework), Supplementary Note 1, for more details.","Homo sapiens","9606","flowSet","HDCytoData/Weber_AML_sim/Weber_AML_sim_main_blasts_all_flowSet.rda"
"3.10",NA,"FCS","http://imlspenticton.uzh.ch/robinson_lab/HDCytoData/",NA,TRUE,"","Lukas M. Weber <lukmweber@gmail.com>","Rda","Weber_AML_sim_null_SE","Semi-simulated mass cytometry (CyTOF) dataset from Weber et al. (2019), constructed by computationally 'spiking in' small percentages of AML (acute myeloid leukemia) blast cells into samples of healthy BMMCs (bone marrow mononuclear cells), simulating the phenotype of minimal residual disease (MRD) in AML patients. Additional simulations: null simulations. This dataset can be used to benchmark differential analysis algorithms used to test for differentially abundant rare cell populations. Raw data sourced from Levine et al. (2015), and data generation strategy modified from Arvaniti et al. (2017). See Weber et al. (2019) (paper introducing 'diffcyt' framework), Supplementary Note 1, for more details.","Homo sapiens","9606","SummarizedExperiment","HDCytoData/Weber_AML_sim/Weber_AML_sim_null_SE.rda"
"3.10",NA,"FCS","http://imlspenticton.uzh.ch/robinson_lab/HDCytoData/",NA,TRUE,"","Lukas M. Weber <lukmweber@gmail.com>","Rda","Weber_AML_sim_null_flowSet","Semi-simulated mass cytometry (CyTOF) dataset from Weber et al. (2019), constructed by computationally 'spiking in' small percentages of AML (acute myeloid leukemia) blast cells into samples of healthy BMMCs (bone marrow mononuclear cells), simulating the phenotype of minimal residual disease (MRD) in AML patients. Additional simulations: null simulations. This dataset can be used to benchmark differential analysis algorithms used to test for differentially abundant rare cell populations. Raw data sourced from Levine et al. (2015), and data generation strategy modified from Arvaniti et al. (2017). See Weber et al. (2019) (paper introducing 'diffcyt' framework), Supplementary Note 1, for more details.","Homo sapiens","9606","flowSet","HDCytoData/Weber_AML_sim/Weber_AML_sim_null_flowSet.rda"
"3.10",NA,"FCS","http://imlspenticton.uzh.ch/robinson_lab/HDCytoData/",NA,TRUE,"","Lukas M. Weber <lukmweber@gmail.com>","Rda","Weber_AML_sim_random_seeds_5pc_SE","Semi-simulated mass cytometry (CyTOF) dataset from Weber et al. (2019), constructed by computationally 'spiking in' small percentages of AML (acute myeloid leukemia) blast cells into samples of healthy BMMCs (bone marrow mononuclear cells), simulating the phenotype of minimal residual disease (MRD) in AML patients. Additional simulations: modified random seeds. This dataset can be used to benchmark differential analysis algorithms used to test for differentially abundant rare cell populations. Raw data sourced from Levine et al. (2015), and data generation strategy modified from Arvaniti et al. (2017). See Weber et al. (2019) (paper introducing 'diffcyt' framework), Supplementary Note 1, for more details.","Homo sapiens","9606","SummarizedExperiment","HDCytoData/Weber_AML_sim/Weber_AML_sim_random_seeds_5pc_SE.rda"
"3.10",NA,"FCS","http://imlspenticton.uzh.ch/robinson_lab/HDCytoData/",NA,TRUE,"","Lukas M. Weber <lukmweber@gmail.com>","Rda","Weber_AML_sim_random_seeds_5pc_flowSet","Semi-simulated mass cytometry (CyTOF) dataset from Weber et al. (2019), constructed by computationally 'spiking in' small percentages of AML (acute myeloid leukemia) blast cells into samples of healthy BMMCs (bone marrow mononuclear cells), simulating the phenotype of minimal residual disease (MRD) in AML patients. Additional simulations: modified random seeds. This dataset can be used to benchmark differential analysis algorithms used to test for differentially abundant rare cell populations. Raw data sourced from Levine et al. (2015), and data generation strategy modified from Arvaniti et al. (2017). See Weber et al. (2019) (paper introducing 'diffcyt' framework), Supplementary Note 1, for more details.","Homo sapiens","9606","flowSet","HDCytoData/Weber_AML_sim/Weber_AML_sim_random_seeds_5pc_flowSet.rda"
"3.10",NA,"FCS","http://imlspenticton.uzh.ch/robinson_lab/HDCytoData/",NA,TRUE,"","Lukas M. Weber <lukmweber@gmail.com>","Rda","Weber_AML_sim_random_seeds_1pc_SE","Semi-simulated mass cytometry (CyTOF) dataset from Weber et al. (2019), constructed by computationally 'spiking in' small percentages of AML (acute myeloid leukemia) blast cells into samples of healthy BMMCs (bone marrow mononuclear cells), simulating the phenotype of minimal residual disease (MRD) in AML patients. Additional simulations: modified random seeds. This dataset can be used to benchmark differential analysis algorithms used to test for differentially abundant rare cell populations. Raw data sourced from Levine et al. (2015), and data generation strategy modified from Arvaniti et al. (2017). See Weber et al. (2019) (paper introducing 'diffcyt' framework), Supplementary Note 1, for more details.","Homo sapiens","9606","SummarizedExperiment","HDCytoData/Weber_AML_sim/Weber_AML_sim_random_seeds_1pc_SE.rda"
"3.10",NA,"FCS","http://imlspenticton.uzh.ch/robinson_lab/HDCytoData/",NA,TRUE,"","Lukas M. Weber <lukmweber@gmail.com>","Rda","Weber_AML_sim_random_seeds_1pc_flowSet","Semi-simulated mass cytometry (CyTOF) dataset from Weber et al. (2019), constructed by computationally 'spiking in' small percentages of AML (acute myeloid leukemia) blast cells into samples of healthy BMMCs (bone marrow mononuclear cells), simulating the phenotype of minimal residual disease (MRD) in AML patients. Additional simulations: modified random seeds. This dataset can be used to benchmark differential analysis algorithms used to test for differentially abundant rare cell populations. Raw data sourced from Levine et al. (2015), and data generation strategy modified from Arvaniti et al. (2017). See Weber et al. (2019) (paper introducing 'diffcyt' framework), Supplementary Note 1, for more details.","Homo sapiens","9606","flowSet","HDCytoData/Weber_AML_sim/Weber_AML_sim_random_seeds_1pc_flowSet.rda"
"3.10",NA,"FCS","http://imlspenticton.uzh.ch/robinson_lab/HDCytoData/",NA,TRUE,"","Lukas M. Weber <lukmweber@gmail.com>","Rda","Weber_AML_sim_random_seeds_0.1pc_SE","Semi-simulated mass cytometry (CyTOF) dataset from Weber et al. (2019), constructed by computationally 'spiking in' small percentages of AML (acute myeloid leukemia) blast cells into samples of healthy BMMCs (bone marrow mononuclear cells), simulating the phenotype of minimal residual disease (MRD) in AML patients. Additional simulations: modified random seeds. This dataset can be used to benchmark differential analysis algorithms used to test for differentially abundant rare cell populations. Raw data sourced from Levine et al. (2015), and data generation strategy modified from Arvaniti et al. (2017). See Weber et al. (2019) (paper introducing 'diffcyt' framework), Supplementary Note 1, for more details.","Homo sapiens","9606","SummarizedExperiment","HDCytoData/Weber_AML_sim/Weber_AML_sim_random_seeds_0.1pc_SE.rda"
"3.10",NA,"FCS","http://imlspenticton.uzh.ch/robinson_lab/HDCytoData/",NA,TRUE,"","Lukas M. Weber <lukmweber@gmail.com>","Rda","Weber_AML_sim_random_seeds_0.1pc_flowSet","Semi-simulated mass cytometry (CyTOF) dataset from Weber et al. (2019), constructed by computationally 'spiking in' small percentages of AML (acute myeloid leukemia) blast cells into samples of healthy BMMCs (bone marrow mononuclear cells), simulating the phenotype of minimal residual disease (MRD) in AML patients. Additional simulations: modified random seeds. This dataset can be used to benchmark differential analysis algorithms used to test for differentially abundant rare cell populations. Raw data sourced from Levine et al. (2015), and data generation strategy modified from Arvaniti et al. (2017). See Weber et al. (2019) (paper introducing 'diffcyt' framework), Supplementary Note 1, for more details.","Homo sapiens","9606","flowSet","HDCytoData/Weber_AML_sim/Weber_AML_sim_random_seeds_0.1pc_flowSet.rda"
"3.10",NA,"FCS","http://imlspenticton.uzh.ch/robinson_lab/HDCytoData/",NA,TRUE,"","Lukas M. Weber <lukmweber@gmail.com>","Rda","Weber_AML_sim_less_distinct_5pc_SE","Semi-simulated mass cytometry (CyTOF) dataset from Weber et al. (2019), constructed by computationally 'spiking in' small percentages of AML (acute myeloid leukemia) blast cells into samples of healthy BMMCs (bone marrow mononuclear cells), simulating the phenotype of minimal residual disease (MRD) in AML patients. Additional simulations: 'less distinct' spike-in cells. This dataset can be used to benchmark differential analysis algorithms used to test for differentially abundant rare cell populations. Raw data sourced from Levine et al. (2015), and data generation strategy modified from Arvaniti et al. (2017). See Weber et al. (2019) (paper introducing 'diffcyt' framework), Supplementary Note 1, for more details.","Homo sapiens","9606","SummarizedExperiment","HDCytoData/Weber_AML_sim/Weber_AML_sim_less_distinct_5pc_SE.rda"
"3.10",NA,"FCS","http://imlspenticton.uzh.ch/robinson_lab/HDCytoData/",NA,TRUE,"","Lukas M. Weber <lukmweber@gmail.com>","Rda","Weber_AML_sim_less_distinct_5pc_flowSet","Semi-simulated mass cytometry (CyTOF) dataset from Weber et al. (2019), constructed by computationally 'spiking in' small percentages of AML (acute myeloid leukemia) blast cells into samples of healthy BMMCs (bone marrow mononuclear cells), simulating the phenotype of minimal residual disease (MRD) in AML patients. Additional simulations: 'less distinct' spike-in cells. This dataset can be used to benchmark differential analysis algorithms used to test for differentially abundant rare cell populations. Raw data sourced from Levine et al. (2015), and data generation strategy modified from Arvaniti et al. (2017). See Weber et al. (2019) (paper introducing 'diffcyt' framework), Supplementary Note 1, for more details.","Homo sapiens","9606","flowSet","HDCytoData/Weber_AML_sim/Weber_AML_sim_less_distinct_5pc_flowSet.rda"
"3.10",NA,"FCS","http://imlspenticton.uzh.ch/robinson_lab/HDCytoData/",NA,TRUE,"","Lukas M. Weber <lukmweber@gmail.com>","Rda","Weber_AML_sim_less_distinct_1pc_SE","Semi-simulated mass cytometry (CyTOF) dataset from Weber et al. (2019), constructed by computationally 'spiking in' small percentages of AML (acute myeloid leukemia) blast cells into samples of healthy BMMCs (bone marrow mononuclear cells), simulating the phenotype of minimal residual disease (MRD) in AML patients. Additional simulations: 'less distinct' spike-in cells. This dataset can be used to benchmark differential analysis algorithms used to test for differentially abundant rare cell populations. Raw data sourced from Levine et al. (2015), and data generation strategy modified from Arvaniti et al. (2017). See Weber et al. (2019) (paper introducing 'diffcyt' framework), Supplementary Note 1, for more details.","Homo sapiens","9606","SummarizedExperiment","HDCytoData/Weber_AML_sim/Weber_AML_sim_less_distinct_1pc_SE.rda"
"3.10",NA,"FCS","http://imlspenticton.uzh.ch/robinson_lab/HDCytoData/",NA,TRUE,"","Lukas M. Weber <lukmweber@gmail.com>","Rda","Weber_AML_sim_less_distinct_1pc_flowSet","Semi-simulated mass cytometry (CyTOF) dataset from Weber et al. (2019), constructed by computationally 'spiking in' small percentages of AML (acute myeloid leukemia) blast cells into samples of healthy BMMCs (bone marrow mononuclear cells), simulating the phenotype of minimal residual disease (MRD) in AML patients. Additional simulations: 'less distinct' spike-in cells. This dataset can be used to benchmark differential analysis algorithms used to test for differentially abundant rare cell populations. Raw data sourced from Levine et al. (2015), and data generation strategy modified from Arvaniti et al. (2017). See Weber et al. (2019) (paper introducing 'diffcyt' framework), Supplementary Note 1, for more details.","Homo sapiens","9606","flowSet","HDCytoData/Weber_AML_sim/Weber_AML_sim_less_distinct_1pc_flowSet.rda"
"3.10",NA,"FCS","http://imlspenticton.uzh.ch/robinson_lab/HDCytoData/",NA,TRUE,"","Lukas M. Weber <lukmweber@gmail.com>","Rda","Weber_AML_sim_less_distinct_0.1pc_SE","Semi-simulated mass cytometry (CyTOF) dataset from Weber et al. (2019), constructed by computationally 'spiking in' small percentages of AML (acute myeloid leukemia) blast cells into samples of healthy BMMCs (bone marrow mononuclear cells), simulating the phenotype of minimal residual disease (MRD) in AML patients. Additional simulations: 'less distinct' spike-in cells. This dataset can be used to benchmark differential analysis algorithms used to test for differentially abundant rare cell populations. Raw data sourced from Levine et al. (2015), and data generation strategy modified from Arvaniti et al. (2017). See Weber et al. (2019) (paper introducing 'diffcyt' framework), Supplementary Note 1, for more details.","Homo sapiens","9606","SummarizedExperiment","HDCytoData/Weber_AML_sim/Weber_AML_sim_less_distinct_0.1pc_SE.rda"
"3.10",NA,"FCS","http://imlspenticton.uzh.ch/robinson_lab/HDCytoData/",NA,TRUE,"","Lukas M. Weber <lukmweber@gmail.com>","Rda","Weber_AML_sim_less_distinct_0.1pc_flowSet","Semi-simulated mass cytometry (CyTOF) dataset from Weber et al. (2019), constructed by computationally 'spiking in' small percentages of AML (acute myeloid leukemia) blast cells into samples of healthy BMMCs (bone marrow mononuclear cells), simulating the phenotype of minimal residual disease (MRD) in AML patients. Additional simulations: 'less distinct' spike-in cells. This dataset can be used to benchmark differential analysis algorithms used to test for differentially abundant rare cell populations. Raw data sourced from Levine et al. (2015), and data generation strategy modified from Arvaniti et al. (2017). See Weber et al. (2019) (paper introducing 'diffcyt' framework), Supplementary Note 1, for more details.","Homo sapiens","9606","flowSet","HDCytoData/Weber_AML_sim/Weber_AML_sim_less_distinct_0.1pc_flowSet.rda"
"3.10",NA,"FCS","http://imlspenticton.uzh.ch/robinson_lab/HDCytoData/",NA,TRUE,"","Lukas M. Weber <lukmweber@gmail.com>","Rda","Weber_BCR_XL_sim_main_SE","Semi-simulated mass cytometry (CyTOF) dataset from Weber et al. (2019), constructed by randomly splitting unstimulated (reference) samples of PBMCs (peripheral blood mononuclear cells) into two halves, and replacing B cells in one half with stimulated (BCR-XL) B cells from corresponding paired samples. Main simulation. This dataset can be used to benchmark differential analysis algorithms used to test for differential states within cell populations. Raw data sourced from Bodenmiller et al. (2012); cell population labels reproduced from Nowicka et al. (2017). See Weber et al. (2019) (paper introducing 'diffcyt' framework), Supplementary Note 1, for more details.","Homo sapiens","9606","SummarizedExperiment","HDCytoData/Weber_BCR_XL_sim/Weber_BCR_XL_sim_main_SE.rda"
"3.10",NA,"FCS","http://imlspenticton.uzh.ch/robinson_lab/HDCytoData/",NA,TRUE,"","Lukas M. Weber <lukmweber@gmail.com>","Rda","Weber_BCR_XL_sim_main_flowSet","Semi-simulated mass cytometry (CyTOF) dataset from Weber et al. (2019), constructed by randomly splitting unstimulated (reference) samples of PBMCs (peripheral blood mononuclear cells) into two halves, and replacing B cells in one half with stimulated (BCR-XL) B cells from corresponding paired samples. Main simulation. This dataset can be used to benchmark differential analysis algorithms used to test for differential states within cell populations. Raw data sourced from Bodenmiller et al. (2012); cell population labels reproduced from Nowicka et al. (2017). See Weber et al. (2019) (paper introducing 'diffcyt' framework), Supplementary Note 1, for more details.","Homo sapiens","9606","flowSet","HDCytoData/Weber_BCR_XL_sim/Weber_BCR_XL_sim_main_flowSet.rda"
"3.10",NA,"FCS","http://imlspenticton.uzh.ch/robinson_lab/HDCytoData/",NA,TRUE,"","Lukas M. Weber <lukmweber@gmail.com>","Rda","Weber_BCR_XL_sim_null_rep1_SE","Semi-simulated mass cytometry (CyTOF) dataset from Weber et al. (2019), constructed by randomly splitting unstimulated (reference) samples of PBMCs (peripheral blood mononuclear cells) into two halves, and replacing B cells in one half with stimulated (BCR-XL) B cells from corresponding paired samples. Additional simulations: null simulations. This dataset can be used to benchmark differential analysis algorithms used to test for differential states within cell populations. Raw data sourced from Bodenmiller et al. (2012); cell population labels reproduced from Nowicka et al. (2017). See Weber et al. (2019) (paper introducing 'diffcyt' framework), Supplementary Note 1, for more details.","Homo sapiens","9606","SummarizedExperiment","HDCytoData/Weber_BCR_XL_sim/Weber_BCR_XL_sim_null_rep1_SE.rda"
"3.10",NA,"FCS","http://imlspenticton.uzh.ch/robinson_lab/HDCytoData/",NA,TRUE,"","Lukas M. Weber <lukmweber@gmail.com>","Rda","Weber_BCR_XL_sim_null_rep1_flowSet","Semi-simulated mass cytometry (CyTOF) dataset from Weber et al. (2019), constructed by randomly splitting unstimulated (reference) samples of PBMCs (peripheral blood mononuclear cells) into two halves, and replacing B cells in one half with stimulated (BCR-XL) B cells from corresponding paired samples. Additional simulations: null simulations. This dataset can be used to benchmark differential analysis algorithms used to test for differential states within cell populations. Raw data sourced from Bodenmiller et al. (2012); cell population labels reproduced from Nowicka et al. (2017). See Weber et al. (2019) (paper introducing 'diffcyt' framework), Supplementary Note 1, for more details.","Homo sapiens","9606","flowSet","HDCytoData/Weber_BCR_XL_sim/Weber_BCR_XL_sim_null_rep1_flowSet.rda"
"3.10",NA,"FCS","http://imlspenticton.uzh.ch/robinson_lab/HDCytoData/",NA,TRUE,"","Lukas M. Weber <lukmweber@gmail.com>","Rda","Weber_BCR_XL_sim_null_rep2_SE","Semi-simulated mass cytometry (CyTOF) dataset from Weber et al. (2019), constructed by randomly splitting unstimulated (reference) samples of PBMCs (peripheral blood mononuclear cells) into two halves, and replacing B cells in one half with stimulated (BCR-XL) B cells from corresponding paired samples. Additional simulations: null simulations. This dataset can be used to benchmark differential analysis algorithms used to test for differential states within cell populations. Raw data sourced from Bodenmiller et al. (2012); cell population labels reproduced from Nowicka et al. (2017). See Weber et al. (2019) (paper introducing 'diffcyt' framework), Supplementary Note 1, for more details.","Homo sapiens","9606","SummarizedExperiment","HDCytoData/Weber_BCR_XL_sim/Weber_BCR_XL_sim_null_rep2_SE.rda"
"3.10",NA,"FCS","http://imlspenticton.uzh.ch/robinson_lab/HDCytoData/",NA,TRUE,"","Lukas M. Weber <lukmweber@gmail.com>","Rda","Weber_BCR_XL_sim_null_rep2_flowSet","Semi-simulated mass cytometry (CyTOF) dataset from Weber et al. (2019), constructed by randomly splitting unstimulated (reference) samples of PBMCs (peripheral blood mononuclear cells) into two halves, and replacing B cells in one half with stimulated (BCR-XL) B cells from corresponding paired samples. Additional simulations: null simulations. This dataset can be used to benchmark differential analysis algorithms used to test for differential states within cell populations. Raw data sourced from Bodenmiller et al. (2012); cell population labels reproduced from Nowicka et al. (2017). See Weber et al. (2019) (paper introducing 'diffcyt' framework), Supplementary Note 1, for more details.","Homo sapiens","9606","flowSet","HDCytoData/Weber_BCR_XL_sim/Weber_BCR_XL_sim_null_rep2_flowSet.rda"
"3.10",NA,"FCS","http://imlspenticton.uzh.ch/robinson_lab/HDCytoData/",NA,TRUE,"","Lukas M. Weber <lukmweber@gmail.com>","Rda","Weber_BCR_XL_sim_null_rep3_SE","Semi-simulated mass cytometry (CyTOF) dataset from Weber et al. (2019), constructed by randomly splitting unstimulated (reference) samples of PBMCs (peripheral blood mononuclear cells) into two halves, and replacing B cells in one half with stimulated (BCR-XL) B cells from corresponding paired samples. Additional simulations: null simulations. This dataset can be used to benchmark differential analysis algorithms used to test for differential states within cell populations. Raw data sourced from Bodenmiller et al. (2012); cell population labels reproduced from Nowicka et al. (2017). See Weber et al. (2019) (paper introducing 'diffcyt' framework), Supplementary Note 1, for more details.","Homo sapiens","9606","SummarizedExperiment","HDCytoData/Weber_BCR_XL_sim/Weber_BCR_XL_sim_null_rep3_SE.rda"
"3.10",NA,"FCS","http://imlspenticton.uzh.ch/robinson_lab/HDCytoData/",NA,TRUE,"","Lukas M. Weber <lukmweber@gmail.com>","Rda","Weber_BCR_XL_sim_null_rep3_flowSet","Semi-simulated mass cytometry (CyTOF) dataset from Weber et al. (2019), constructed by randomly splitting unstimulated (reference) samples of PBMCs (peripheral blood mononuclear cells) into two halves, and replacing B cells in one half with stimulated (BCR-XL) B cells from corresponding paired samples. Additional simulations: null simulations. This dataset can be used to benchmark differential analysis algorithms used to test for differential states within cell populations. Raw data sourced from Bodenmiller et al. (2012); cell population labels reproduced from Nowicka et al. (2017). See Weber et al. (2019) (paper introducing 'diffcyt' framework), Supplementary Note 1, for more details.","Homo sapiens","9606","flowSet","HDCytoData/Weber_BCR_XL_sim/Weber_BCR_XL_sim_null_rep3_flowSet.rda"
"3.10",NA,"FCS","http://imlspenticton.uzh.ch/robinson_lab/HDCytoData/",NA,TRUE,"","Lukas M. Weber <lukmweber@gmail.com>","Rda","Weber_BCR_XL_sim_random_seeds_rep1_SE","Semi-simulated mass cytometry (CyTOF) dataset from Weber et al. (2019), constructed by randomly splitting unstimulated (reference) samples of PBMCs (peripheral blood mononuclear cells) into two halves, and replacing B cells in one half with stimulated (BCR-XL) B cells from corresponding paired samples. Additional simulations: modified random seeds. This dataset can be used to benchmark differential analysis algorithms used to test for differential states within cell populations. Raw data sourced from Bodenmiller et al. (2012); cell population labels reproduced from Nowicka et al. (2017). See Weber et al. (2019) (paper introducing 'diffcyt' framework), Supplementary Note 1, for more details.","Homo sapiens","9606","SummarizedExperiment","HDCytoData/Weber_BCR_XL_sim/Weber_BCR_XL_sim_random_seeds_rep1_SE.rda"
"3.10",NA,"FCS","http://imlspenticton.uzh.ch/robinson_lab/HDCytoData/",NA,TRUE,"","Lukas M. Weber <lukmweber@gmail.com>","Rda","Weber_BCR_XL_sim_random_seeds_rep1_flowSet","Semi-simulated mass cytometry (CyTOF) dataset from Weber et al. (2019), constructed by randomly splitting unstimulated (reference) samples of PBMCs (peripheral blood mononuclear cells) into two halves, and replacing B cells in one half with stimulated (BCR-XL) B cells from corresponding paired samples. Additional simulations: modified random seeds. This dataset can be used to benchmark differential analysis algorithms used to test for differential states within cell populations. Raw data sourced from Bodenmiller et al. (2012); cell population labels reproduced from Nowicka et al. (2017). See Weber et al. (2019) (paper introducing 'diffcyt' framework), Supplementary Note 1, for more details.","Homo sapiens","9606","flowSet","HDCytoData/Weber_BCR_XL_sim/Weber_BCR_XL_sim_random_seeds_rep1_flowSet.rda"
"3.10",NA,"FCS","http://imlspenticton.uzh.ch/robinson_lab/HDCytoData/",NA,TRUE,"","Lukas M. Weber <lukmweber@gmail.com>","Rda","Weber_BCR_XL_sim_random_seeds_rep2_SE","Semi-simulated mass cytometry (CyTOF) dataset from Weber et al. (2019), constructed by randomly splitting unstimulated (reference) samples of PBMCs (peripheral blood mononuclear cells) into two halves, and replacing B cells in one half with stimulated (BCR-XL) B cells from corresponding paired samples. Additional simulations: modified random seeds. This dataset can be used to benchmark differential analysis algorithms used to test for differential states within cell populations. Raw data sourced from Bodenmiller et al. (2012); cell population labels reproduced from Nowicka et al. (2017). See Weber et al. (2019) (paper introducing 'diffcyt' framework), Supplementary Note 1, for more details.","Homo sapiens","9606","SummarizedExperiment","HDCytoData/Weber_BCR_XL_sim/Weber_BCR_XL_sim_random_seeds_rep2_SE.rda"
"3.10",NA,"FCS","http://imlspenticton.uzh.ch/robinson_lab/HDCytoData/",NA,TRUE,"","Lukas M. Weber <lukmweber@gmail.com>","Rda","Weber_BCR_XL_sim_random_seeds_rep2_flowSet","Semi-simulated mass cytometry (CyTOF) dataset from Weber et al. (2019), constructed by randomly splitting unstimulated (reference) samples of PBMCs (peripheral blood mononuclear cells) into two halves, and replacing B cells in one half with stimulated (BCR-XL) B cells from corresponding paired samples. Additional simulations: modified random seeds. This dataset can be used to benchmark differential analysis algorithms used to test for differential states within cell populations. Raw data sourced from Bodenmiller et al. (2012); cell population labels reproduced from Nowicka et al. (2017). See Weber et al. (2019) (paper introducing 'diffcyt' framework), Supplementary Note 1, for more details.","Homo sapiens","9606","flowSet","HDCytoData/Weber_BCR_XL_sim/Weber_BCR_XL_sim_random_seeds_rep2_flowSet.rda"
"3.10",NA,"FCS","http://imlspenticton.uzh.ch/robinson_lab/HDCytoData/",NA,TRUE,"","Lukas M. Weber <lukmweber@gmail.com>","Rda","Weber_BCR_XL_sim_random_seeds_rep3_SE","Semi-simulated mass cytometry (CyTOF) dataset from Weber et al. (2019), constructed by randomly splitting unstimulated (reference) samples of PBMCs (peripheral blood mononuclear cells) into two halves, and replacing B cells in one half with stimulated (BCR-XL) B cells from corresponding paired samples. Additional simulations: modified random seeds. This dataset can be used to benchmark differential analysis algorithms used to test for differential states within cell populations. Raw data sourced from Bodenmiller et al. (2012); cell population labels reproduced from Nowicka et al. (2017). See Weber et al. (2019) (paper introducing 'diffcyt' framework), Supplementary Note 1, for more details.","Homo sapiens","9606","SummarizedExperiment","HDCytoData/Weber_BCR_XL_sim/Weber_BCR_XL_sim_random_seeds_rep3_SE.rda"
"3.10",NA,"FCS","http://imlspenticton.uzh.ch/robinson_lab/HDCytoData/",NA,TRUE,"","Lukas M. Weber <lukmweber@gmail.com>","Rda","Weber_BCR_XL_sim_random_seeds_rep3_flowSet","Semi-simulated mass cytometry (CyTOF) dataset from Weber et al. (2019), constructed by randomly splitting unstimulated (reference) samples of PBMCs (peripheral blood mononuclear cells) into two halves, and replacing B cells in one half with stimulated (BCR-XL) B cells from corresponding paired samples. Additional simulations: modified random seeds. This dataset can be used to benchmark differential analysis algorithms used to test for differential states within cell populations. Raw data sourced from Bodenmiller et al. (2012); cell population labels reproduced from Nowicka et al. (2017). See Weber et al. (2019) (paper introducing 'diffcyt' framework), Supplementary Note 1, for more details.","Homo sapiens","9606","flowSet","HDCytoData/Weber_BCR_XL_sim/Weber_BCR_XL_sim_random_seeds_rep3_flowSet.rda"
"3.10",NA,"FCS","http://imlspenticton.uzh.ch/robinson_lab/HDCytoData/",NA,TRUE,"","Lukas M. Weber <lukmweber@gmail.com>","Rda","Weber_BCR_XL_sim_less_distinct_less_50pc_SE","Semi-simulated mass cytometry (CyTOF) dataset from Weber et al. (2019), constructed by randomly splitting unstimulated (reference) samples of PBMCs (peripheral blood mononuclear cells) into two halves, and replacing B cells in one half with stimulated (BCR-XL) B cells from corresponding paired samples. Additional simulations: 'less distinct' spike-in cells. This dataset can be used to benchmark differential analysis algorithms used to test for differential states within cell populations. Raw data sourced from Bodenmiller et al. (2012); cell population labels reproduced from Nowicka et al. (2017). See Weber et al. (2019) (paper introducing 'diffcyt' framework), Supplementary Note 1, for more details.","Homo sapiens","9606","SummarizedExperiment","HDCytoData/Weber_BCR_XL_sim/Weber_BCR_XL_sim_less_distinct_less_50pc_SE.rda"
"3.10",NA,"FCS","http://imlspenticton.uzh.ch/robinson_lab/HDCytoData/",NA,TRUE,"","Lukas M. Weber <lukmweber@gmail.com>","Rda","Weber_BCR_XL_sim_less_distinct_less_50pc_flowSet","Semi-simulated mass cytometry (CyTOF) dataset from Weber et al. (2019), constructed by randomly splitting unstimulated (reference) samples of PBMCs (peripheral blood mononuclear cells) into two halves, and replacing B cells in one half with stimulated (BCR-XL) B cells from corresponding paired samples. Additional simulations: 'less distinct' spike-in cells. This dataset can be used to benchmark differential analysis algorithms used to test for differential states within cell populations. Raw data sourced from Bodenmiller et al. (2012); cell population labels reproduced from Nowicka et al. (2017). See Weber et al. (2019) (paper introducing 'diffcyt' framework), Supplementary Note 1, for more details.","Homo sapiens","9606","flowSet","HDCytoData/Weber_BCR_XL_sim/Weber_BCR_XL_sim_less_distinct_less_50pc_flowSet.rda"
"3.10",NA,"FCS","http://imlspenticton.uzh.ch/robinson_lab/HDCytoData/",NA,TRUE,"","Lukas M. Weber <lukmweber@gmail.com>","Rda","Weber_BCR_XL_sim_less_distinct_less_75pc_SE","Semi-simulated mass cytometry (CyTOF) dataset from Weber et al. (2019), constructed by randomly splitting unstimulated (reference) samples of PBMCs (peripheral blood mononuclear cells) into two halves, and replacing B cells in one half with stimulated (BCR-XL) B cells from corresponding paired samples. Additional simulations: 'less distinct' spike-in cells. This dataset can be used to benchmark differential analysis algorithms used to test for differential states within cell populations. Raw data sourced from Bodenmiller et al. (2012); cell population labels reproduced from Nowicka et al. (2017). See Weber et al. (2019) (paper introducing 'diffcyt' framework), Supplementary Note 1, for more details.","Homo sapiens","9606","SummarizedExperiment","HDCytoData/Weber_BCR_XL_sim/Weber_BCR_XL_sim_less_distinct_less_75pc_SE.rda"
"3.10",NA,"FCS","http://imlspenticton.uzh.ch/robinson_lab/HDCytoData/",NA,TRUE,"","Lukas M. Weber <lukmweber@gmail.com>","Rda","Weber_BCR_XL_sim_less_distinct_less_75pc_flowSet","Semi-simulated mass cytometry (CyTOF) dataset from Weber et al. (2019), constructed by randomly splitting unstimulated (reference) samples of PBMCs (peripheral blood mononuclear cells) into two halves, and replacing B cells in one half with stimulated (BCR-XL) B cells from corresponding paired samples. Additional simulations: 'less distinct' spike-in cells. This dataset can be used to benchmark differential analysis algorithms used to test for differential states within cell populations. Raw data sourced from Bodenmiller et al. (2012); cell population labels reproduced from Nowicka et al. (2017). See Weber et al. (2019) (paper introducing 'diffcyt' framework), Supplementary Note 1, for more details.","Homo sapiens","9606","flowSet","HDCytoData/Weber_BCR_XL_sim/Weber_BCR_XL_sim_less_distinct_less_75pc_flowSet.rda"
